AI assistant
TruScreen Group Limited — Share Issue/Capital Change 2018
Sep 25, 2018
66285_rns_2018-09-25_e2845055-a813-4332-8098-5ff5d02347af.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
25 September 2018
Company Announcement
TruScreen Share Placement
ISSUE OF SECURITIES BY
TRUSCREEN LIMITED (TRU)
TruScreen Limited advises that it has issued new shares as follows: Class of Security: Ordinary Shares (TRU) Number issued: 100,000 ordinary shares at NZD 10 cents each fully paid Payment: Cash on subscription Percentage of total Class of Securities issued: 0.05% (of the total number of ordinary shares on issue post completion of the issue) Reason for the issue: Exercise of options awarded to Mr Yaniv Gal by Directors Resolution on 8 October, 2014: Authority of issue : Director’s Resolution and Certificate Terms of issue: The new shares are credited as fully paid, and rank in all respects equally with the shares already on issue. Total number of securities of the Class in existence after the issue: 209,445,477 Date of issue: 25 September 2018
TRUSCREEN LIMITED
Martin Dillon
Chief Executive Officer
-ENDS-
For more information visit www.truscreen.com
or contact
Martin Dillon,
TruScreen Chief Executive Officer, email: [email protected]
About TruScreen:
TruScreen’s real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection.
==> picture [297 x 186] intentionally omitted <==